Literature DB >> 7814141

Characterisation of four Merkel cell carcinoma adherent cell lines.

J H Leonard1, P Dash, P Holland, J H Kearsley, J R Bell.   

Abstract

We have previously described the establishment of a number of cell lines from Merkel cell carcinoma (MCC), also known as small cell cancer of the skin or neuroendocrine carcinoma of the skin. These cells, all of which grew as suspension cultures, were found to resemble small cell lung cancer (SCLC) lines types 1, 2 and 3 by their morphology and growth characteristics. We now report 4 more MCC cell lines which resemble the SCLC type 4 cell lines in that they grow as adherent monolayers. These MCC lines would belong to the variant subgroup as they no longer express most neuroendocrine markers, grow at low cell density and have population doubling times of 1-5 days in contrast to the MCC suspension lines which have doubling times of 6-12 days. MCC14/1 and MCC14/2 were established from the same metastatic node and would appear to represent 2 clones of the tumour which differ in morphology, histochemical markers and DNA content. We present details of the morphology, DNA content and immunohistochemistry of these 4 lines and compare their growth patterns with those of SCLC and MCC lines which grow in suspension.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7814141     DOI: 10.1002/ijc.2910600115

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  18 in total

1.  Activation of PI3K signaling in Merkel cell carcinoma.

Authors:  Valentina Nardi; Youngchul Song; Juan A Santamaria-Barria; Arjola K Cosper; Quynh Lam; Anthony C Faber; Genevieve M Boland; Beow Y Yeap; Kristin Bergethon; Vanessa L Scialabba; Hensin Tsao; Jeffrey Settleman; David P Ryan; Darrell R Borger; Atul K Bhan; Mai P Hoang; Anthony J Iafrate; James C Cusack; Jeffrey A Engelman; Dora Dias-Santagata
Journal:  Clin Cancer Res       Date:  2012-01-18       Impact factor: 12.531

2.  Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens.

Authors:  Roland Houben; Masahiro Shuda; Rita Weinkam; David Schrama; Huichen Feng; Yuan Chang; Patrick S Moore; Jürgen C Becker
Journal:  J Virol       Date:  2010-05-05       Impact factor: 5.103

3.  Downregulation of MHC-I expression is prevalent but reversible in Merkel cell carcinoma.

Authors:  Kelly G Paulson; Andrew Tegeder; Christoph Willmes; Jayasri G Iyer; Olga K Afanasiev; David Schrama; Shinichi Koba; Renee Thibodeau; Kotaro Nagase; William T Simonson; Aaron Seo; David M Koelle; Margaret Madeleine; Shailender Bhatia; Hideki Nakajima; Shigetoshi Sano; James S Hardwick; Mary L Disis; Michele A Cleary; Jürgen C Becker; Paul Nghiem
Journal:  Cancer Immunol Res       Date:  2014-08-12       Impact factor: 11.151

4.  Lack of integrin β5 in Merkel cell carcinomas and derived cell lines is frequently associated with Merkel cell polyomavirus positivity.

Authors:  Baki Akgül; Paola Zigrino; Martin Hufbauer; Xi Liu; Patrick S Moore; Cornelia Mauch; Herbert Pfister
Journal:  J Dermatol Sci       Date:  2012-03-30       Impact factor: 4.563

5.  Human CD4+ T Cells Specific for Merkel Cell Polyomavirus Localize to Merkel Cell Carcinomas and Target a Required Oncogenic Domain.

Authors:  Paul Nghiem; William W Kwok; David M Koelle; Natalie V Longino; Junbao Yang; Jayasri G Iyer; Dafina Ibrani; I-Ting Chow; Kerry J Laing; Victoria L Campbell; Kelly G Paulson; Rima M Kulikauskas; Candice D Church; Eddie A James
Journal:  Cancer Immunol Res       Date:  2019-08-12       Impact factor: 11.151

6.  T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus.

Authors:  Masahiro Shuda; Huichen Feng; Hyun Jin Kwun; Steven T Rosen; Ole Gjoerup; Patrick S Moore; Yuan Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-23       Impact factor: 11.205

7.  Characterization of an early passage Merkel cell polyomavirus-positive Merkel cell carcinoma cell line, MS-1, and its growth in NOD scid gamma mice.

Authors:  Anna Guastafierro; Huichen Feng; Mamie Thant; John M Kirkwood; Yuan Chang; Patrick S Moore; Masahiro Shuda
Journal:  J Virol Methods       Date:  2012-10-18       Impact factor: 2.014

8.  ALK is frequently phosphorylated in Merkel cell carcinoma and associates with longer survival.

Authors:  Jenni Jaatinen; Tuukka Veija; Marko Salmikangas; Tom Böhling; Harri Sihto; Virve Koljonen
Journal:  PLoS One       Date:  2021-05-24       Impact factor: 3.240

9.  Activation of the PI3K/AKT pathway in Merkel cell carcinoma.

Authors:  Christian Hafner; Roland Houben; Anne Baeurle; Cathrin Ritter; David Schrama; Michael Landthaler; Juergen C Becker
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

10.  Identification of natural product modulators of Merkel cell carcinoma cell growth and survival.

Authors:  Emily A Smith; Natasha T Hill; Tara Gelb; Khalid A Garman; Ekaterina I Goncharova; Heidi R Bokesch; Chang-Kwon Kim; Karen L Wendt; Robert H Cichewicz; Kirk R Gustafson; Isaac Brownell; Curtis J Henrich
Journal:  Sci Rep       Date:  2021-06-30       Impact factor: 4.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.